Increased our position in Inari Medical, Inc. due to attractive valuations for a market-leading medical device company. Inari dominates the PE market and has significant growth opportunities in both ...

Needham initiated coverage on Inari Medical Inc (NASDAQ:NARI), noting it as a leader in the very large and underpenetrated market for venous thrombectomy. Inari Medical projects an annual patient ...

Baron Funds, an investment management company, released its “Baron Discovery Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here. In the third quarter, the fund ...

Inari Medical Inc. is tapping Tel Aviv-based Aidoc’s artificial intelligence-based software and workflow for the rapid detection of pulmonary embolism (PE). The Irvine-based company’s FlowTriever ...

Sorrento Therapeutics Inc. has divulged antibody-drug conjugates comprising antibodies targeting HER2 covalently linked to exatecan through a linker. They are ...